Effects of the new calcium antagonist mibefradil (Ro 40-5967) on exercise duration in patients with chronic stable angina pectoris: a multicenter, placebo-controlled study. Ro 40-5967 International Study Group.
暂无分享,去创建一个
E. E. van der Wall | A. Bruschke | A. L. Bakx | S. Braun | H. Emanuelsson | I. Kobrin | A. V. Bruschke | E. E. Wall